KEROS THERAPEUTICS INC (KROS) Stock Earnings & Estimates
NASDAQ:KROS - US4923271013 - Common Stock
15.47 USD
-0.12 (-0.77%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 151K | 3.55M 2,250.99% | 201.62M 5,579.44% | 5.1M -97.47% | 13.73M 169.22% | 63.023M 359.02% | 101.39M 60.88% | 116.19M 14.60% | 220.9M 90.12% | 287.97M 30.36% | |
| EBITDA YoY % growth | -114.12M -103.82% | -169.126M -48.20% | -209.604M -23.93% | -795.6K 99.62% | -124.787M -15,584.62% | -83.232M 33.30% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -114.79M -103.64% | -169.941M -48.05% | -210.833M -24.06% | -29.198M 86.15% | -214.728M -635.41% | -214.208M 0.24% | -198.465M 7.35% | -170.27M 14.21% | -180.402M -5.95% | -123.582M 31.50% | -118.997M 3.71% | |
| Operating Margin | N/A | -112,543.71% | -5,938.96% | -14.48% | -4,210.35% | -1,560.15% | -314.91% | -167.94% | -155.26% | -55.94% | -41.32% | |
| EPS YoY % growth | -4.15 -64.68% | -5.20 -25.30% | -5.01 3.65% | -0.05 99.03% | -4.67 -9,537.43% | -4.68 -0.15% | -2.97 36.43% | -1.86 37.55% | -1.74 6.14% | 0.02 100.94% | 0.08 362.50% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.14 19.46% | -1.11 2.67% | -1.23 -134.02% | -1.25 -64.07% | -1.28 -12.50% | -1.14 -2.73% | -1.25 -1.86% | -1.26 -1.43% | -1.08 15.37% | -0.97 14.99% |
| Revenue Q2Q % growth | 4.307M 1,010.05% | 3.241M 6.54% | -100.00% | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -55.702M 3.56% | -51.755M 0.52% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -53.946M 8.03% | -53.805M -1.03% | -56.17M -136.94% | -56.518M -41.94% | -58.906M -9.19% | -51.094M 5.04% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.76 39.20% | -1.15 | 0.39 | 34.17% |
| Q1 2025 Q2Q % growth | 3.62 399.17% | -0.25 | 3.87 | 1,560.50% |
| Q4 2024 Q2Q % growth | -1.14 14.93% | -1.00 | -0.14 | -13.69% |
| Q3 2024 Q2Q % growth | -1.41 -6.02% | -1.30 | -0.11 | -8.05% |
| Q2 2024 Q2Q % growth | -1.25 1.57% | -1.26 | 0.01 | 0.53% |
| Q1 2024 Q2Q % growth | -1.21 3.97% | -1.37 | 0.16 | 11.93% |
| Q4 2023 Q2Q % growth | -1.34 -22.94% | -1.40 | 0.06 | 4.43% |
| Q3 2023 Q2Q % growth | -1.33 -44.57% | -1.37 | 0.04 | 3.25% |
| Q2 2023 Q2Q % growth | -1.27 -12.39% | -1.37 | 0.10 | 6.98% |
| Q1 2023 Q2Q % growth | -1.26 -24.75% | -1.15 | -0.11 | -10.01% |
| Q4 2022 Q2Q % growth | -1.09 -263.33% | -1.12 | 0.03 | 2.60% |
| Q3 2022 Q2Q % growth | -0.92 -5.75% | -1.26 | 0.34 | 26.77% |
| Q2 2022 Q2Q % growth | -1.13 -68.66% | -1.08 | -0.05 | -4.71% |
| Q1 2022 Q2Q % growth | -1.01 -48.53% | -0.88 | -0.13 | -14.81% |
| Q4 2021 Q2Q % growth | -0.30 38.78% | -0.94 | 0.64 | 67.94% |
| Q3 2021 Q2Q % growth | -0.87 -45.00% | -0.74 | -0.13 | -18.05% |
| Q2 2021 Q2Q % growth | -0.67 -8.06% | -0.67 | 0.00 | -0.28% |
| Q1 2021 Q2Q % growth | -0.68 86.69% | -0.59 | -0.09 | -14.94% |
| Q4 2020 Q2Q % growth | -0.49 | -0.58 | 0.09 | 15.72% |
| Q3 2020 Q2Q % growth | -0.60 | -0.61 | 0.01 | 1.14% |
| Q2 2020 Q2Q % growth | -0.62 | -0.69 | 0.07 | 9.95% |
| Q1 2020 Q2Q % growth | -5.11 | -0.38 | -4.73 | -1,254.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 18.168M 49,002.70% | 2.822M | 15.346M | 543.80% |
| Q1 2025 Q2Q % growth | 211.246M 254,413.25% | 2.227M | 209.019M | 9,385.68% |
| Q4 2024 Q2Q % growth | 3.042M 2,027.27% | 15.732M | -12.69M | -80.66% |
| Q2 2023 Q2Q % growth | 165.75K | -165.75K | -100.00% | |
| Q1 2023 Q2Q % growth | 221.003K | -221.003K | -100.00% | |
| Q4 2022 Q2Q % growth | -100.00% | 874.283K | -874.283K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | 6.12M | -6.12M | -100.00% | |
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | 63.75K | -63.75K | -100.00% |
| Q2 2020 Q2Q % growth | -100.00% | 63.75K | -63.75K | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | 84.997K | -84.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.03% | 1.48% | 92.91% | 97.99% |
| Revenue | 18.36% | 67.07% | 3.44% | 36.77% |